Prostaglandin E 2 (PGE 2 ) is a principal fever mediator that induces hyperthermia when injected into the organum vasculosum lamina terminalis (OVLT) and the adjacent preoptic area of the hypothalamus (POA). PGE (EP) receptors have four subtypes, i.e. EP 1 , EP 2 , EP 3 , and EP 4 . In the rat OVLT/POA region, at least three of these receptors, i.e. EP 1 , EP 3 , and EP 4 receptors, have distinctively different distribution patterns. In rats, intracerebroventricular injection of EP 1 receptor agonists and EP 3 receptor agonists increased core temperature (Tc) and that of an EP 4 receptor agonist decreased it. IntraPOA injection of an EP 1 receptor agonist increased Tc. IntraPOA injection of an EP 3 receptor agonist, however, induced hyperalgesia but not hyperthermia. Studies using mice with EP receptor gene deletions have indicated that EP 3 receptors play a crucial role in febrile response. Therefore, the involvement of EP 3 receptors at other levels of the nervous system should be considered. Such nuclei include the raphe pallidus nucleus, intermediolateral cell column in the spinal cord, or the nucleus of the solitary tract.
ABSTRACT
Prostaglandin E 2 (PGE 2 ) is a principal fever mediator that induces hyperthermia when injected into the organum vasculosum lamina terminalis (OVLT) and the adjacent preoptic area of the hypothalamus (POA). PGE (EP) receptors have four subtypes, i.e. EP 1 , EP 2 , EP 3 , and EP 4 . In the rat OVLT/POA region, at least three of these receptors, i.e. EP 1 , EP 3 , and EP 4 receptors, have distinctively different distribution patterns. In rats, intracerebroventricular injection of EP 1 receptor agonists and EP 3 receptor agonists increased core temperature (Tc) and that of an EP 4 receptor agonist decreased it. IntraPOA injection of an EP 1 receptor agonist increased Tc. IntraPOA injection of an EP 3 receptor agonist, however, induced hyperalgesia but not hyperthermia. Studies using mice with EP receptor gene deletions have indicated that EP 3 receptors play a crucial role in febrile response. Therefore, the involvement of EP 3 receptors at other levels of the nervous system should be considered. Such nuclei include the raphe pallidus nucleus, intermediolateral cell column in the spinal cord, or the nucleus of the solitary tract.
INTRODUCTION
After Milton and Wendlandt (1970) reported that injection of prostaglandin (PG) E 1 into the third ventricle elevated body temperature in cats (1), much attention has been focused on PGEs as principal mediators of fever. Since prostaglandin E 2 (PGE 2 ) is the predominant isoform of PGE in the brain, PGE 2 is currently considered to be an essential mediator of fever (2). Investigators have subsequently sought to identify the sites where PGEs act to produce fever by microinjecting PGE 1 , PGE 2 , and PGE receptor agonists into the brains of rats (3-6) and other species (7-10). These studies localized the site of PGE 2 febrigenic activity to within the anteroventral tip of the third ventricle, including the organum vasculosum of the lamina terminalis (OVLT) and the adjacent preoptic area (POA).
In the 1990s, the PGE (EP) receptor was cloned, and four subtypes were identified: EP 1 , EP 2 , EP 3 , and EP 4 . The EP receptors are all G-protein-coupled receptors, but they have different signal transduction pathways, i.e. elevation of intracellular Ca 2+ (EP 1 ) and stimulation of adenylate cyclase (EP 2 and EP 4 ). The major signaling pathway for the EP 3 receptor is inhibition of adenylate cyclase. However, the EP 3 receptor has several isoforms (three in rats and mice, four in cows, and seven in humans), and these splicing variants of EP 3 receptors are coupled to different signaling pathways (11-13) (table 1).
In this decade, researchers have discovered that each EP receptor has its own distinctive distribution pattern within the OVLT/POA region (14-21) and that each EP receptor plays a different role in the acute phase response, including fever (6, 11, 22-25), sleep (26, 27), activation of hypothalamic-pituitary-adrenal axis (28), and changes in nociception (29-35). Researchers have also proposed several efferent neural pathways from the PGE 2 -sensitive febrogenic zone to the interscapular brown adipose tissue (BAT), the major organ for thermogenesis (36) (37) (38) (39) (40) (41) (42) . This article reviews recent advances in understanding the role that EP receptors play in the febrile response.
EP RECEPTORS IN THE PGE 2 -SENSITIVE FEBROGENIC ZONE

PGE 2 sensitive febrogenic zone
Fever is induced by elevation of PGE 2 in the brain. Inflammatory stimuli may cause fever through activation of cyclooxygenase-2 (COX-2) and microsomal PGE synthase in brain endothelial cells (43-45) or in perivascular cells (46, 47) . PGE 2 is then released from these cells into the brain and acts on the EP receptor-expressing neurons, resulting in fever (for further details, see (48-50)). Within this region, the hyperthermic action of PGE is more potent when it is microinjected into the anteroventral region of the third ventricle (AV3V), which includes the OVLT, the median preoptic nucleus (MnPO), and the ventromedial preoptic nucleus (VMPO), compared with other regions within the POA (4). This observation was confirmed by an electrophysiological study demonstrating that OVLT neurons respond to PGE 2 at lower doses than do POA neurons (58). Scammell et al. injected a minute volume of PGE 2 (10 -100 nl) and observed that the induced hyperthermia was most pronounced when PGE 2 was microinjected into the cellsparse zone below the diagonal band of Broca, the meningeal strand supporting the optic chiasm and parenchyma immediately above the strand, the MnPO, the VMPO, and the anteroventral periventricular nucleus (AVPV) (5) (figure 1).
EP Receptor distribution within the OVLT/POA region
To assess which EP receptor subtypes are expressed within the PGE 2 -sensitive febrogenic zone, we mapped the distribution of EP 1-4 receptor messenger RNA (mRNA) in the OVLT/POA region in rats and found that at least three of these receptors, i.e. the EP 1 , EP 3 , and EP 4 receptors, have distinctively different distribution patterns (20). In the meningeal strand which supports the optic chiasm, only EP 1 receptor mRNA was found. In the OVLT, EP 1 receptor mRNA was expressed in the medial part, and EP 4 receptor mRNA was expressed in the lateral part. Low levels of EP 3 receptor mRNA were found within the OVLT. In the POA, both EP 3 receptor mRNA and EP 4 receptor mRNA were strongly expressed in the MnPO and in the border region between the medial preoptic area (MPO) and the lateral preoptic area (LPO), forming an inverted Y shape. EP 4 receptor mRNA was also observed within the VMPO and the AVPV, while EP 3 receptor mRNA was not seen in both nuclei. EP 1 receptor mRNA was distributed diffusely throughout the POA (table 2 and figure 2). EP 2 receptor mRNA is reportedly expressed within the MPO (17). These anatomical studies thus indicate that all four EP receptors are distributed within the PGE 2 -sensitive febrogenic zone and that they are expressed on neurons (14-21). Other cell types, such as astrocytes (60), microglia (61), or cerebral microvessel endothelial cells (62-64) are also known to express some EP receptor subtypes. Although the involvement of glial cells in the PGE 2 -mediated febrile response is proposed (2), it awaits further study if EP receptors on non-neuronal cells contribute to the development of fever. 
Activated EP receptors during fever response
Subsequently, we assessed the coexpression of LPS-induced Fos-like immunoreactivity (Fos-LI) and EP 1-4 receptor mRNA in nuclei in the rat OVLT/POA region to investigate which EP receptor-expressing neurons are activated during fever (20). Intravenous (i.v.) injection of LPS (5 µg/kg) produced a 1 o C rise in core temperature (Tc) within 2 hours. At this time point, LPS-induced Fos-LI was observed in the VMPO, in the MnPO, and in the border region between the MPO and the LPO. Within these areas, most Fos-immunoreactive neurons (70-80 %) contained EP 4 receptor mRNA, and about half of them (50-60%) contained EP 1 receptor mRNA. In contrast, despite strong EP 3 receptor mRNA expression within the MnPO, few Fos-immunoreactive neurons (<10%) contained EP 3 receptor mRNA (figure 2).
This high coexpression of Fos-LI and EP 4 receptor mRNA indicates that EP 4 receptor-expressing neurons are activated during LPS-induced fever and suggests some role for EP 4 receptors in the development of fever. However, since the c-fos gene is activated by either increased intracellular Ca 2+ or cAMP, this high coexpression might simply reflect differences in signal transduction pathways between EP isoforms: stimulation of EP 4 receptors increases cAMP, whereas stimulation of the EP 1 receptor increases intracellular Ca
2+
, and stimulation of EP 3 receptor decreases or increases cAMP depending on its isoform (65, 66) . The functional role of activated EP 4 receptor-expressing POA neurons in febrile response should thus be considered in conjunction with physiological studies.
EFFECTS OF EP RECEPTOR AGONISTS ON BODY TEMPERATURE
To determine which EP receptor mediates febrile response, we therefore injected EP receptor agonists and antagonists into the rat brain and observed changes in core injection of SC19220 (an EP 1 receptor antagonist) blocked PGE 2 (i.c.v.)-induced hyperthermia (22, 67). Microinjection of 17-phenyl-ω-trinor PGE 2 into the OVLT/POA region also increased Tc, whereas microinjections of butaprost and M&B28767 did not increase Tc. The 17-phenyl-ω-trinor PGE 2 -induced hyperthermic effect was stronger in the AV3V than the POA. These findings suggest an EP 1 receptor mediation of PGE 2 -induced hyperthermia in rats (6). Because of the low selectivity of these agonists to specific receptor subtypes (with the exception of butaprost) (12, 13), a similar pharmacological study was performed using a new generation of more selective EP agonist drugs (24, 68). I.c.v. injection of DI-004 (2 and 20 nmol), an EP 1 receptor agonist, increased Tc in a dose dependent manner with a peak 30 min after injection. ONO-AE1-259-01 (20 nmol), an EP 2 receptor agonist, did not change Tc. ONO-AE-248 (20 nmol), an EP 3 receptor agonist, also increased Tc, but its peak effect was delayed (50 min after injection) compared with PGE 2 (30 min after injection). Given that ONO-AE-248 has more than a 1000-fold higher affinity for EP 3 receptors than for EP 1 receptors (68) and that it inhibits the forskolin-induced increase in cAMP (69), the results with ONO-AE-248 suggest that while EP 3 receptors also may mediate hyperthermia, they probably employ different mechanisms than those associated with EP 1 receptors. In contrast, ONO-AE1-329 (2 nmol), an EP 4 receptor agonist, decreased Tc (figure 3) (24).
To summarize, pharmacological studies in rats suggest that the EP 1 and EP 3 receptors mediate a hyperthermic action and that the EP 4 receptor mediates a hypothermic action. A similar pharmacological study in pigs suggests that the EP 2 receptor is necessary for fever production (70).
FEBRILE RESPONSE IN EP RECEPTOR KOCKOUT MICE
Another approach to understanding the mechanisms for the febrile response is to assess responses to pyrogens in mice with EP receptor gene deletions. Ushikubi (73, 74) and cytokines (75, 76) that differ from the neural pathways and cytokines associated with systemic inflammation-induced fever.
[3] Most importantly, did Ushikubi et al. properly control for the effects of stress hyperthermia? After they administered LPS (i.v.), IL-1β (i.v.), and PGE 2 (i.c.v.) to their mice, the resultant elevations in Tc all peaked 20 min after injections, a pattern which coincides with the temperature response pattern of psychological stress-induced hyperthermia (77, 78) . Thus it is possible that they merely observed stress-induced hyperthermia, and that the impaired rise in Tc that their EP 3 receptor KO mice exhibited in response to LPS and IL-1β might be due to a resistance to stress-induced hyperthermia unique to EP 3 receptor KO mice.
To address these questions, we extended the experiments of Ushikubi et al. by observing changes in Tc using telemetry in wild type (WT) mice, EP 1 receptor KO mice, and EP 3 receptor KO mice (78) (figure 4). [1] We investigated for at least 10 hours following injection the effect of intraperitoneal (i.p.) LPS on Tc over a range of LPS dosages (1 µg/kg -1 mg/kg). In WT mice, i.p. injection of LPS at 10 µg/kg induced the early (within 60 min) and the middle (2 -3 hrs) phases of fever. At 100 µg/kg, LPS induced the late phase (5 -10 hrs) of fever in addition to early and middle phases. At 1 mg/kg, LPS decreased Tc, possibly due to endotoxin shock. In EP 1 receptor KO mice, LPS at 10 µg/kg reduced the early phase, but not the middle phase of fever . LPS at 100 µg/kg suppressed fever completely. LPS at 1 mg/kg exacerbated hypothermia. In EP 3 receptor KO mice, LPS lowered Tc in a dose-and time-dependent manner. Diurnal changes in Tc remained normal in both EP 1 and EP 3 receptor KO mice. [2] We also investigated the effect of the subcutaneous (s.c.) injection of turpentine on Tc over a 48 hr observation period. S.c. injection of turpentine induced fever in EP 1 receptor KO mice and WT mice, but it did not induce fever in EP 3 receptor KO mice.
[3] Psychological stress, including cageexchange stress and buddy-removal stress, induced a monophasic hyperthermia peaking at 20 min in both EP 1 receptor KO mice and EP 3 receptor KO mice. These patterns of hyperthermia were identical to those observed in WT mice. Therefore, inhibition of stress-induced hyperthermia is not a mechanism responsible for impairment of the febrile response in EP 3 receptor KO mice. Although pharmacological studies in rats suggest that the EP 1 and EP 3 receptors mediate a hyperthermic action and that the EP 4 receptor mediates a hypothermic action, our study suggests that in mice, EP 3 receptors play a crucial role in fever responses to both systemic inflammation and local inflammation. EP 1 receptors may be partially involved in LPS-induced fever.
CHANGES IN FIRING RATE RESPONSES OF OVLT/POA NEURONS BY PGE 2
Electrophysiological studies have shown that i.v. injection of IL-1β, a pyrogenic cytokine, changes the firing rate of neurons within the OVLT/POA region, i.e. it inhibits 50% of neurons in the AV3V and the MnPO, and it also excites 30% of them (table 3) (79) . According to Hammel's model, fever is induced by inhibiting firing rate of warm-sensitive (W) neurons and exciting that of temperature-insensitive (I) neurons in the hypothalamus (80) . In accordance with this, direct bath application of PGE 2 predominantly inhibited the activity of W neurons in the OVLT (58) and in the VMPO (59) and excited that of I neurons in the VMPO (59) in rat tissue slices. In the POA, however, PGE 2 excited a considerable population of W neurons (57, 58). In any case, since PGE 2 -induced changes in the firing rate of the thermosensitive neurons were still observed even in a Ca 2+ free and high Mg 2+ solution which blocks synaptic activity, post-synaptic responsiveness of OVLT and POA neurons to PGE 2 is suggested (58).
So far, however, researchers have not definitively identified which EP receptors are involved in inhibition or excitation of thermosensitive or temperature-insensitive neuronal activities. Available evidence indicates that AH6809, an EP 1 and/or D type PG receptor antagonist (12), blocks the PGE 2 -induced inhibition of both OVLT and POA neurons (58).
EFFERENT FEVER-PRODUCING PATHWAYS FROM THE OVLT/POA REGION
As described above, the action of PGE 2 on neurons in the OVLT/POA region is thought to be crucial for fever induction. However, the neuroanatomical chain of functionally connected neurons from the PGE 2 -sensitive febrogenic zone to the effectors that contribute to fever induction has not yet been fully demonstrated. The interscapular BAT is the major organ for non-shivering thermogenesis during fever and the tail artery contributes to fever development by inhibiting heat-loss via vasoconstriction in rats. Therefore, to define the central circuitry responsible for the febrile response, pseudorabies virus (PRV) was injected into the interscapular BAT, and the distribution of infected neurons was traced in rats (37, 38, 42) and hamsters (81) . In the rat forebrain, infected neurons were found in the OVLT, the ventral MnPO, the 40 % of virally infected POA neurons expressed EP 3 receptor-LI (38). About 90% of EP 3 receptorimmunoreactive POA neurons exhibited signals for GAD67 mRNA. EP 3 receptor-expressing GABAergic neurons send direct projections to the rostral raphe pallidus nucleus (RPa) (36). The RPa contains the sympathetic premotor neurons responsible for BAT thermogenesis (83) and vasoconstriction of the tail artery (84, 85), both of which contribute to the febrile response. IntraPOA PGE 2 microinjection-induced BAT thermogenesis was blocked by the microinjection of muscimol, a GABA A receptor agonist, into the RPa (36). In addition, microinjection of bicuculline, a GABA A receptor antagonist, into the RPa increased sympathetic nerve activity (SNA) to the BAT in rats (83). Therefore, it is reasonable to hypothesize that EP 3 receptor-expressing GABAergic POA neurons tonically inhibit RPa neurons and that a PGE 2 -triggered mechanism in the POA effectively relieves the tonic inhibition of the RPa neurons, leading to the excitation of SNA to the BAT and the tail artery, thereby producing fever (36, 81).
IntraPOA
PGE 2 microinjection-induced hyperthermia was also attenuated by microinjection of kynurenate, an ionotropic excitatory amino acid (EAA) receptor antagonist, into the RPa (39) or the DMH (40). These findings suggest that a PGE 2 -induced disinhibition of the RPa neurons is not the sole mechanism for producing fever and that activation of EAA receptors in the DMH or the RPa is also necessary for the BAT thermogenesis evoked by microinjection of PGE 2 into the POA. Involvement of other hypothalamic nuclei, including the paraventricular hypothalamic nucleus (87-89) and the posterior hypothalamus (90) , has also been reported. Furthermore, PRV-infected nuclei include the lateral hypothalamic, perifornical and retrochiasmatic nuclei, ventrolateral periaqueductal gray matter, the lateral parabrachial nucleus, and the nucleus of the solitary tract (NTS) (37, 38, 42). So far, however, it remains unknown whether EP 3 -receptor expressing or other EP receptorsexpressing POA neurons send excitatory output to the RPa or the DMH, and it also remains unknown how specific EP receptor-expressing neurons affect neurons within other PRV-infected nuclei.
PERSPECTIVES
The EP 3 receptor is undoubtably crucial for the febrile response in mice. On the other hand, i.c.v. or intraPOA injection of EP 1 receptor agonists produces more potent hyperthermia than EP 3 receptor agonists in rats (6, 22, 24). IntraPOA injection of PGE 2 induces hyperalgesia and hyperthermia, whereas injection of M&B28767, an EP 3 receptor agonist, induces hyperalgesia but has little effect on Tc in rats (6, 33). Furthermore, lesions in the PGE 2 -sensitive febrogenic zone did not attenuate PGE 1 or PGE 2 -induced hyperthermia in squirrel monkeys (91) or rats (92) . These findings raise a question whether the OVLT/POA region is really the only site where PGE 2 acts on EP 3 receptors (or other EP receptors) to produce hyperthermia. EP 3 receptor mRNA or immunoreactivity has been demonstrated at other levels of the nervous system, e.g. in the RPa, the intermediolateral cell column (IML) in the spinal cord, and vagal afferents in the NTS (18, 19 93), and in peripheral cells such as macrophages (94, 95) . It may be possible that EP 3 receptors in these regions or cell types also contribute to febrile response. For example, twothirds of infected RPa neurons that polysynaptically project to the interscapular BAT expressed EP 3 receptor-LI (38). Bath application of PGE 2 and M&B28767 depolarized the membrane of dorsal raphe neurons (96) . These findings suggest that RPa neurons themselves might possess PG sensitivity that is able to modulate BAT thermogenesis under febrile conditions. Therefore, future studies should include investigation of the role of EP 3 receptors in the RPa, IML, or NTS in thermoregulatory and febrile responses.
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